Trial
NCT00003453
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Stage IV Adrenocortical Carcinoma
Intervention
Antineoplaston therapy (Atengenal + Astugenal)
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-09